<SEC-DOCUMENT>0001193125-24-086673-index.html : 20240404 <SEC-HEADER>0001193125-24-086673.hdr.sgml : 20240404 <ACCEPTANCE-DATETIME>20240404084535 ACCESSION NUMBER: 0001193125-24-086673 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 EFFECTIVENESS DATE: 20240404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sanofi CENTRAL INDEX KEY: 0001121404 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133529324 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-278502 FILM NUMBER: 24821750 BUSINESS ADDRESS: STREET 1: 46 AVENUE DE LA GRANDE ARMEE CITY: PARIS STATE: I0 ZIP: 75017 BUSINESS PHONE: 33153774400 MAIL ADDRESS: STREET 1: 46 AVENUE DE LA GRANDE ARMEE CITY: PARIS STATE: I0 ZIP: 75017 FORMER COMPANY: FORMER CONFORMED NAME: SANOFI-AVENTIS DATE OF NAME CHANGE: 20040826 FORMER COMPANY: FORMER CONFORMED NAME: SANOFI SYNTHELABO SA DATE OF NAME CHANGE: 20010104 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>d803515ds8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: d803515ds8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.5 <SEQUENCE>2 <FILENAME>d803515dex45.htm <DESCRIPTION>EX-4.5 <TEXT> Document 2 - file: d803515dex45.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>d803515dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: d803515dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>d803515dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 4 - file: d803515dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>5 <FILENAME>d803515dex232.htm <DESCRIPTION>EX-23.2 <TEXT> Document 5 - file: d803515dex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>6 <FILENAME>d803515dexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 6 - file: d803515dexfilingfees.htm
</DOCUMENT> </SEC-DOCUMENT>